Please login to the form below

Not currently logged in
Email:
Password:

Merck's chair retires

Richard T Clark, chair of Merck (known as MSD outside the US and Canada) is to retire from the pharmaceutical company on December 1, 2011

Richard T Clark - MerckRichard T Clark, chair of Merck (known as MSD outside the US and Canada) is to retire from the pharmaceutical company on December 1, 2011.

He will be replaced by current CEO, Kenneth C Frazier who was elected by the board of directors.

Clark joined Merck in 1972 as a quality control inspector, and became chair in 2010. Other roles during his time at the company include president and CEO from 2005 to 2010, senior vice president of quality and commercial affairs, and president of the company's manufacturing division.

He said: "I have been a part of Merck for more than 39 years – I always have and always will consider Merck to be an important part of my life and my extended family. It has been a great pleasure to work with the talented, dedicated people of Merck who are so committed to our mission of saving and improving lives around the world."

During his time as CEO, Clark oversaw the successful launches of HIV treatment Isentress (raltegravir) and the HPV vaccine Gardasil.

He also led the company's $49bn merger with Schering-Plough in 2009.

10th October 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics